Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Avicursen by Percheron Therapeutics for Duchenne Muscular Dystrophy: Likelihood of Approval
Avicursen is under clinical development by Percheron Therapeutics and currently in Phase II for Duchenne Muscular Dystrophy. According to GlobalData,...